Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-09-17FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental BLA for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited. The action concerns regulatory approval rel…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease [Phase 3]
This clinical trial update reports results from an extension Phase 3 study of oral ozanimod for moderately to severely active Crohn's diseas…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease [Phase 2]
Biocad is conducting a Phase 2 clinical study to assess the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of BCD-…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease [Phase 4]
A Phase 4 study evaluating ustekinumab (Stelara) in Chinese participants with moderately to severely active Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease [Phase 2]
A Phase 2 clinical trial evaluating EXL01 for preventing postsurgical recurrence in Crohn's disease is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Risankizumab for Fibrostenotic Crohn's Disease Treatment [Phase 3]
A Phase 3 trial of risankizumab (Skyrizi) for fibrostenotic Crohn's disease is planned, with a not-yet-recruiting status; Crohn's disease an…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease Patients [Phase 1]
A Phase 1 clinical trial investigating vitamin D (cholecalciferol) supplementation for inflammatory bowel disease, with enrollment not yet s…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
This is an update on a precision-medicine clinical trial for inflammatory bowel disease at Seoul National University Hospital, enrolling for…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants. [NA]
A clinical trial update from Assistance Publique - Hôpitaux de Paris evaluating determinants of progression and complications in inflammator…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: High-protein Oral Nutrition With HMB for Active CD Patients With Sarcopenia [NA]
A clinical trial assessing whether high-protein oral nutrition with HMB improves muscle strength in active Crohn's disease patients with sar…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD [NA]
The clinical trial evaluating a fasting-mimicking diet for depressive symptoms in inflammatory bowel disease has completed. The study includ…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease
A completed observational clinical trial tracking the natural course of silent small bowel narrowing in adults with Crohn's disease to under…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD
This entry describes an upcoming clinical study from McMaster University investigating protease regulation and the role of sodium in inflamm…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Evaluation of a Multimodal Day Hospital for the Overall Management of Patients With Chronic Inflammatory Bowel Diseases (IBD)
The document reports a clinical trial investigating a multimodal day hospital approach for managing chronic inflammatory bowel diseases, inc…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. [Phase 3]
A Phase 3 clinical trial update evaluating subcutaneous risankizumab induction for moderately to severely active Crohn's disease, focusing o…
-
EMA withdrawal · 2025-09-08EMA Withdrawn: Eksunbi (ustekinumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn Eksunbi (ustekinumab) from the European market as of 23 May 2025, affecting indications for Crohn's disease, ulcerativ…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Multiple Digital Biomarkers for Optimization of IBD Care
A clinical trial is evaluating multiple digital biomarkers to optimize care for inflammatory bowel disease, including Crohn's disease and ul…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Implementation of Point Of Care UltraSound in the Assessment of Crohn's Disease -The POCUS Study
A clinical trial evaluating point-of-care ultrasound for assessing Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease [Phase 2]
Phase 2 trial evaluating BI 706321 in combination with ustekinumab for Crohn's disease was terminated, with results posted.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease
This study establishes a prospective cohort and conducts clinical observation in pediatric Crohn's disease patients. It is sponsored by Tong…
-
FDA approval · 2025-09-03FDA Approved: INFLECTRA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Inflectra (infliximab-dyyb) from Pfizer to update its labeling and/or indications, following…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Description of the Radiological Response of Anoperineal Fistulizing Lesions of Crohn's Disease
The document reports on radiological response of anoperineal fistulizing lesions in Crohn's disease from a completed clinical trial update.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With Refractory Crohn's Disease: A Multicenter, Randomized, Parallel-Controlled Study [Phase 3]
Phase 3 multicenter randomized study evaluating induction and maintenance therapy with ustekinumab and upadacitinib in patients with refract…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
A real-world study in Poland evaluating Vedolizumab for adults with ulcerative colitis or Crohn's disease has completed.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study [NA]
An open-label randomized controlled study evaluating the efficacy and mechanism of fecal microbiota transplantation for inflammatory bowel d…